by admin_prosemble | 2nd December 2025 | News
On 2 December 2025, Inna Zhuranskaya and Judy Kingswolf-Yamakawa attended an exclusive Q&A session hosted by Gill Jennings & Every LLP (GJE), Europe’s top-ranked patent law firm according to the Financial Times. The workshop, designed for Lab Ready tenants,...
by admin_prosemble | 2nd December 2025 | News
On 2 December 2025, Inna Zhuranskaya and Judy Kingswolf-Yamakawa attended the AI Breakfast Club in London, a key event for AI founders, innovators, and enthusiasts. This special edition of the breakfast focused on AI’s transformative potential in health and...
by admin_prosemble | 20th November 2025 | News
Judy Kingswolf-Yamakawa attended the Women’s Innovation Showcase on 20 November as part of London Life Sciences Week. The event focused on women’s health, fertility, hormones, and emerging life science ventures. Prosemble represented our nanoparticle oncology research...
by admin_prosemble | 19th November 2025 | News
Prosemble is proud to announce that Inna Zhuranskaya and Dr. Ludovico Pipito were honoured at the MedX@Düsseldorf soirée with a prestigious award for their groundbreaking work in AI/ML platforms for drug discovery and protein nanoparticles for drug delivery. The award...
by admin_prosemble | 19th November 2025 | News
Judy Kingswolf-Yamakawa showcased Prosemble’s technology at the Bench to Business Forum, part of London Life Sciences Showcase. Her pitch was one of the most well-received of the day, sparking productive conversations with founders, academic groups, and investors from...
